Form 4 for JANX Janux Therapeutics, Inc.
Accepted 2025-01-03 00:00:00 ET · period of report 2025-01-02 · accession 0001415889-25-000554 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-01-03 | 2025-01-02 | JANX | Meyer Andrew Hollman | Chief Business Off | S - Sale | $54.88 | -13.3K | 82.1K | -14% | -$731.8K |
| D | 2025-01-03 | 2025-01-02 | JANX | Meyer Andrew Hollman | Chief Business Off | A - Grant | $0.00 | +18.0K | 95.5K | +23% | $0 |
| D | 2025-01-03 | 2025-01-02 | JANX | Meyer Andrew Hollman | Chief Business Off | A - Grant | $0.00 | +63.0K | 63.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-02 | S | D | 5,768 | $54.51 | 86,783 | D | — | — | (F4) The weighted average sale price for the transaction reported was $54.5111 and the range of prices were between $54.21 and $55.14. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 2 | Common | Common Stock | 2025-01-02 | S | D | 2,922 | $53.76 | 92,551 | D | — | — | (F3) The weighted average sale price for the transaction reported was $53.7582 and the range of prices were between $53.20 and $54.18. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 3 | Common | Common Stock | 2025-01-02 | A | A | 18,000 | $0.00 | 95,473 | D | — | — | (F1) Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on January 1, 2026. |
| 4 | Common | Common Stock | 2025-01-02 | S | D | 1,000 | $56.78 | 82,339 | D | — | — | (F6) The weighted average sale price for the transaction reported was $56.7778 and the range of prices were between $56.33 and $57.32. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 5 | Common | Common Stock | 2025-01-02 | S | D | 3,444 | $55.76 | 83,339 | D | — | — | (F5) The weighted average sale price for the transaction reported was $55.7587 and the range of prices were between $55.24 and $56.23. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 6 | Common | Common Stock | 2025-01-02 | S | D | 200 | $57.37 | 82,139 | D | — | — | (F7) The weighted average sale price for the transaction reported was $57.365 and the range of prices were between $57.35 and $57.38. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 7 | Derivative | Stock option (right to buy) | 2025-01-02 | A | A | 63,000 | $0.00 | 63,000 | D | $53.24 · — to 2035-01-01 | 63,000 Common Stock | (F8) 25% of the shares subject to the option vest on January 1, 2026 and the balance will vest in equal monthly installments thereafter over a three year period. |